Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Mirum Pharmaceuticals (MIRM) Return on Capital Employed (2020 - 2025)

Mirum Pharmaceuticals (MIRM) has 5 years of Return on Capital Employed data on record, last reported at 0.07% in Q3 2025.

  • For Q3 2025, Return on Capital Employed changed N/A year-over-year to 0.07%; the TTM value through Sep 2025 reached 0.07%, changed N/A, while the annual FY2023 figure was 0.26%, 24.0% up from the prior year.
  • Return on Capital Employed reached 0.07% in Q3 2025 per MIRM's latest filing, up from 0.1% in the prior quarter.
  • Across five years, Return on Capital Employed topped out at 0.07% in Q3 2025 and bottomed at 0.86% in Q3 2021.
  • Average Return on Capital Employed over 4 years is 0.47%, with a median of 0.48% recorded in 2022.
  • Peak YoY movement for Return on Capital Employed: dropped -18bps in 2021, then skyrocketed 35bps in 2022.
  • A 4-year view of Return on Capital Employed shows it stood at 0.78% in 2021, then soared by 43bps to 0.45% in 2022, then skyrocketed by 56bps to 0.19% in 2023, then soared by 64bps to 0.07% in 2025.
  • Per Business Quant database, its latest 3 readings for Return on Capital Employed were 0.07% in Q3 2025, 0.1% in Q2 2025, and 0.19% in Q4 2023.